EN DE
STOCK COMPARISON

Medpace Holdings vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how Medpace Holdings (MEDP) and Thermo Fisher Scientific (TMO) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Medpace Holdings trades at $593 versus a fair value of $284 (-52%), while Thermo Fisher Scientific trades at $618 versus $308 (-50%).
Medpace Holdings
MEDP · USD · Health Care
-52%
upside to fair value
overvalued
Price$593
Fair Value$284
Quality86/100
Thermo Fisher Scientific
TMO · USD · Health Care
-50%
upside to fair value
overvalued
Price$618
Fair Value$308
Quality64/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Medpace HoldingsThermo Fisher Scientific
Valuation
33.8×P/E (TTM)29.5×
5.72×P/S (TTM)4.41×
33.35×P/B3.74×
25.2×EV/EBITDA20.0×
3.30×PEG1.74×
−52.1%Fair value upside−50.2%
0.1%Dividend yield0.3%
—Dividend per share$1.76
Profitability
20%Operating margin18%
1.17×EBIT margin trend (5Y)0.74×
77%Return on equity14%
17%Return on assets5%
Growth
27%Revenue growth (YoY)6%
20.1%Avg. growth/yr (3Y)-0.3%
22.3%Avg. growth/yr (5Y)6.7%
+31.8%Value creation/yr+2.6%
Balance & size
21.4×Interest coverage (EBIT/interest)5.7×
0.17×Debt / equity0.67×
$15BMarket cap$199B
healthyGrowth qualityhealthy

Medpace Holdings leads: 8 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Medpace Holdingsof which business quality 84 · market factors 63 Thermo Fisher Scientificof which business quality 60 · market factors 71
ProfitabilityMargins and returns on capital today
89
43
Quality GrowthAre margins and returns improving?
72
31
CashflowEarnings quality: real cash, not paper profit
92
62
Fin. StrengthBalance sheet, leverage, solvency risk
79
60
InvestmentDisciplined investing over empire-building
68
79
Low VolatilityCalm price path (market factor)
40
69
MomentumPrice trend over the last 3–12 months (market factor)
72
68
52W MomentumDistance to the 52-week high (market factor)
74
77
Net IssuanceBuybacks instead of dilution
100
97

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyMedpace HoldingsPrice $593Thermo Fisher ScientificPrice $618
DCF Models-3%close to the price$576-43%below the price$354
Earnings-Based-42%below the price$345-67%below the price$203
Dividend Discount-99%below the price$7.01n/a
Multiples-53%below the price$279-50%below the price$308
Asset-Based-98%below the price$10.77-84%below the price$96.29
Growth DCF0%close to the price$593-53%below the price$288
Economic Profit-59%below the price$246-74%below the price$159
Growth Earnings-21%below the price$469-45%below the price$341
Minimum-99%below the price$7.01-84%below the price$96.29
Maximum0%close to the price$593-43%below the price$354
Median-47%below the price$312-53%below the price$288
Geometric mean-74%below the price$152-63%below the price$229

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Medpace Holdings: 21 of 26 models see the stock below the current price.

Thermo Fisher Scientific: 24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Medpace Holdings
Bear $215Fair Value $284Bull $609
$593 = current price (white tick)
Thermo Fisher Scientific
Bear $171Fair Value $308Bull $385
$618 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Medpace Holdings · Health Care

Quality score86 · Top 25%
Fair value upside-52% · below median

Thermo Fisher Scientific · Health Care

Quality score64 · Top 25%
Fair value upside-50% · below median

Bottom line

As of Sep 5, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Medpace Holdings trades at $593 versus a fair value of $284 (-52%), while Thermo Fisher Scientific trades at $618 versus $308 (-50%).

Medpace Holdings has the higher quality score (86/100).

See the full analysis →
Medpace Holdings · Thermo Fisher Scientific

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Medpace Holdings

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupMerck & Company vs UnitedHealth Group

Related to Thermo Fisher Scientific

Thermo Fisher Scientific vs UnitedHealth GroupAstraZeneca vs UnitedHealth GroupAmgen vs UnitedHealth GroupAbbott Laboratories vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.